Corporate ActionJun 25, 2026, 09:01 AM
AIM ImmunoTech to Vote on Reverse Stock Split, Stock Issuances
AI Summary
AIM ImmunoTech Inc. announced a Special Meeting of Stockholders to be held virtually on July 15, 2026. Shareholders will vote on several proposals, including a potential reverse stock split of up to 1-for-25, at the Board's discretion. Additionally, the company seeks approval for the issuance of common stock exceeding 19.99% of outstanding shares related to the exercise of Class H, I, and J warrants, and the conversion of two promissory notes, all for NYSE American compliance. The Board of Directors strongly recommends voting 'FOR' all proposals.
Key Highlights
- Special Meeting of Stockholders scheduled for July 15, 2026, to vote on key proposals.
- Shareholders to vote on approving a reverse stock split up to 1-for-25 ratio.
- Approval sought for issuing over 19.99% common stock for Class H warrants (May 7, 2026 agreement).
- Approval sought for issuing over 19.99% common stock for Class I warrants (May 20, 2026 agreement).
- Approval sought for issuing over 19.99% common stock for Class J warrants (June 9, 2026 agreement).
- Approval sought for issuing over 19.99% common stock for promissory note (February 16, 2024).
- Approval sought for issuing over 19.99% common stock for promissory note (November 18, 2025).
- Board recommends voting 'FOR' all proposals, including potential meeting adjournment.
Price Impact
More from AIM